CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $326 | -73.5% | 10,000 | -71.4% | 0.32% | -78.3% |
| Q1 2023 | $1,232 | -46.2% | 35,000 | -30.0% | 1.46% | -46.5% |
| Q4 2022 | $2,291 | -99.9% | 50,000 | 0.0% | 2.74% | +1.1% |
| Q3 2022 | $2,423,000 | -38.3% | 50,000 | -50.0% | 2.70% | -35.3% |
| Q2 2022 | $3,929,000 | -51.5% | 100,000 | -54.5% | 4.18% | -38.5% |
| Q1 2022 | $8,098,000 | -35.4% | 220,000 | -20.0% | 6.80% | -28.2% |
| Q4 2021 | $12,535,000 | +27.5% | 275,000 | 0.0% | 9.47% | +29.2% |
| Q3 2021 | $9,829,000 | +52.8% | 275,000 | -15.4% | 7.33% | +57.7% |
| Q2 2021 | $6,432,000 | -14.9% | 325,000 | 0.0% | 4.65% | -17.3% |
| Q1 2021 | $7,560,000 | +11.9% | 325,000 | 0.0% | 5.62% | -10.3% |
| Q4 2020 | $6,754,000 | – | 325,000 | – | 6.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |